Page last updated: 2024-10-24

bupivacaine and Intraventricular Septal Defects

bupivacaine has been researched along with Intraventricular Septal Defects in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stuth, EA1
Berens, RJ1
Staudt, SR1
Robertson, FA1
Scott, JP1
Stucke, AG1
Hoffman, GM1
Troshynski, TJ1
Tweddell, JS1
Zuperku, EJ1

Trials

1 trial available for bupivacaine and Intraventricular Septal Defects

ArticleYear
The effect of caudal vs intravenous morphine on early extubation and postoperative analgesic requirements for stage 2 and 3 single-ventricle palliation: a double blind randomized trial.
    Paediatric anaesthesia, 2011, Volume: 21, Issue:4

    Topics: Airway Management; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Cardiopulmonary Bypass; Chil

2011